Am J Perinatol 2009; 26(9): 641-645
DOI: 10.1055/s-0029-1220794
© Thieme Medical Publishers

Pregnancy Complicated by Triploidy: A Comparison of the Three Karyotypes

Dennis T. McWeeney1 , Santiago Munné2 , Richard C. Miller3 , Natalie A. Cekleniak4 , Stephen A. Contag5 , Joseph R. Wax6 , William J. Polzin7 , William J. Watson1
  • 1Division of Maternal-Fetal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota
  • 2Reprogenetics, Three Regent Street, Saint Barnabas Medical Center, Livingston, New Jersey
  • 3Division of Maternal-Fetal Medicine, Saint Barnabas Medical Center, Livingston, New Jersey
  • 4Institute for Reproductive Medicine and Science, Saint Barnabas Medical Center, Livingston, New Jersey
  • 5Division of Maternal-Fetal Medicine, Wake Forest University, Winston Salem, North Carolina
  • 6Division of Maternal-Fetal Medicine, Maine Medical Center, Portland, Maine
  • 7Division of Maternal-Fetal Medicine, Good Samaritan Medical Center, Cincinnati, Ohio
Further Information

Publication History

Publication Date:
23 April 2009 (online)

ABSTRACT

We evaluated triploid pregnancy to determine whether there are clinically important differences between the three karyotypes: 69,XXX, 69,XXY, and 69,XYY. Prospectively maintained cytogenetic databases at five tertiary care centers were retrospectively reviewed over a 10-year period to identify all triploid pregnancies. Targeted ultrasounds were reviewed to identify fetal and placental findings. Sonographic findings were compared by karyotype. There was a total of 549 triploid gestations; preimplantation genetic diagnosis (PGD) detected 413 triploid embryos, and the cytogenetic databases provided 136 clinical pregnancies with triploidy. In triploid embryos with PGD, the frequency of the 69,XYY karyotype was 8.7% (36/413), compared with 0.74% (1/136) during the first trimester of clinical pregnancies (p = 0.002). In clinical pregnancies, 60% (36/60) of 69,XXY fetuses survived the first trimester of development compared with 69% (52/75) of 69,XXX fetuses (p = NS). No clinically important differences were observed between 69,XXX and 69,XXY karyotypes in terms of type, number, or severity of fetal or placental anomalies. Gestations with a 69,XYY karyotype are found less frequently compared with gestations with a 69,XXX or 69,XXY karyotype. The decline in fetal survival of the 69,XYY triploid karyotype needs further investigation. There are significant abnormalities detected during prenatal sonography in most all clinically recognized cases of triploidy. Sonography cannot reliably distinguish between the 69,XXY and 69,XXX karyotypes.

REFERENCES

  • 1 Jacobs P A, Angell R R, Buchanan I M, Hassold T J, Matsuyama J S, Manuel B. The origin of human triploids.  Ann Hum Genet. 1978;  42 49-57
  • 2 Snijders R JM, Sebire N J, Nicolaides K H. Maternal age and gestational age-specific risk for chromosomal defects.  Fetal Diagn Ther. 1995;  10 356-367
  • 3 Niebuhr E. Triploidy in man. Cytogenetical and clinical aspects.  Humangenetik. 1974;  21 103-125
  • 4 Wertelecki W, Graham Jr J M, Sergovich F R. The clinical syndrome of triploidy.  Obstet Gynecol. 1976;  47 69-76
  • 5 Lindor N M, Ney J A, Gaffey T A, Jenkins R B, Thibodeau S N, DeWald G W. A genetic review of complete and partial hydatidiform moles and nonmolar triploidy.  Mayo Clin Proc. 1992;  67 791-799
  • 6 Ferguson-Smith M A, Yates J R. Maternal age specific rates for chromosome aberrations and factors influencing them: report of a collaborative European study of 52,965 amniocenteses.  Prenat Diagn. 1984;  4 5-44
  • 7 Jacobs P A, Szulman A E, Funkhouser J. Human triploidy: relationship between parental origin of chromosomes and the development of partial mole in the placenta.  Ann Hum Genet. 1982;  46 223-231
  • 8 Doshi N, Surti U, Szulman A E. Morphologic anomalies in triploid liveborn fetuses.  Hum Pathol. 1983;  14 716-723
  • 9 Szulman A E, Philippe E, Boue J G, Boue A. Human triploidy: association with partial hydatidiform moles and nonmolar conceptuses.  Hum Pathol. 1981;  12 1016-1021
  • 10 Jauniaux E. Partial moles: from postnatal to prenatal diagnosis.  Placenta. 1999;  20 379-388
  • 11 Graham Jr J M, Rawnsley E F, Simmons G M et al.. Triploidy: pregnancy complications and clinical findings in seven cases.  Prenat Diagn. 1989;  9 409-419
  • 12 Szulman A E, Surti U. The clinicopathologic profile of the partial hydatidiform mole.  Obstet Gynecol. 1982;  59 597-602
  • 13 Baumer A, Balmer D, Binkert F, Schinzel A. Parental origin and mechanisms of formation of triploidy: a study of 25 cases.  Eur J Hum Genet. 2000;  8 911-917
  • 14 Munné S, Magli C, Cohen J, Morton P, Sadowy S et al.. Positive outcome after preimplantation diagnosis of aneuploidy in human embryos.  Hum Reprod. 1999;  14 2191-2199
  • 15 Gianaroli L, Magil M C, Ferraretti A P, Munné S. Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilization with poor prognosis. Identification of the categories to which it should be proposed.  Fertil Steril. 1999;  72 837-844
  • 16 Munné S, Chen S, Fischer J et al.. Preimplantation genetic diagnosis reduces pregnancy loss in women 35 and older with a history of recurrent miscarriages.  Fertil Steril. 2005;  84 331-335
  • 17 Garrisi J G, Colls P, Ferry K M, Zheng X et al.. Effect of infertility, maternal age and number of previous miscarriage on the outcome of preimplantation genetic diagnosis for idiopathic recurrent pregnancy loss.  Fertil Steril. 2008;  , August 8 (Epub ahead of print)
  • 18 Munné S, Magli C, Bahçe M et al.. Preimplantation diagnosis of the aneuploidies most commonly found in spontaneous abortions and live births: XY, 13, 14, 15, 16, 18, 21, 22.  Prenat Diagn. 1998;  18 1459-1466
  • 19 Colls P, Escudero T, Cekleniak N et al.. Increased efficiency of preimplantation genetic diagnosis for infertility using “no result rescue”.  Fertil Steril. 2007;  88 53-61
  • 20 Snijders R J, Nicolaides K H. Fetal biometry at 14–40 weeks' gestation.  Ultrasound Obstet Gynecol. 1994;  4 34-48
  • 21 Jauniaux E, Brown R, Rodeck C, Nicolaides K H. Prenatal diagnosis of triploidy during the second trimester of pregnancy.  Obstet Gynecol. 1996;  88 983-989
  • 22 Philipp T, Grillenberger K, Separovic E R, Philipp K, Kalousek D K. Effects of triploidy on early human development.  Prenat Diagn. 2004;  24 276-281
  • 23 Huang T, Alberman E, Wald N, Summers A M. Triploidy identified through second trimester serum screening.  Prenat Diagn. 2005;  25 229-233
  • 24 Devriendt K. Hydatidiform mole and triploidy: the role of genomic imprinting in placental development.  Hum Reprod Update. 2005;  11 137-142
  • 25 Braude P, Bolton V, Moore S. Human gene expression first occurs between the four- and eight-cell stages of preimplantation development.  Nature. 1988;  332 459-461
  • 26 Mittal T K, Vujanic G M, Morrissey B M, Jones A. Triploidy: antenatal sonographic features with post-mortem correlation.  Prenat Diagn. 1998;  18 1253-1262
  • 27 Pircon R A, Porto M, Towers C V, Crade M, Gocke S E. Ultrasound findings in pregnancies complicated by fetal triploidy.  J Ultrasound Med. 1989;  8 507-511
  • 28 Benacerraf B R. Intrauterine growth retardation in the first trimester associated with triploidy.  J Ultrasound Med. 1988;  7 153-154
  • 29 Crane J P, Beaver H A, Cheung S W. Antenatal ultrasound findings in fetal triploidy syndrome.  J Ultrasound Med. 1985;  4 519-524

Dennis T McWeeneyD.O. 

Maternal-Fetal Medicine, Mayo Clinic

200 First Street SW, Charlton 3B, Rochester, MN 55905

Email: mcweeney.dennis@mayo.edu